International Consortium for AGP & DTx Research and Development Scientific Research Fund
The widespread adoption of continuous glucose monitoring (CGM) has introduced key metrics such as glycemic variability and Time in Range (TIR), transforming diabetes care and enabling time-based, lifelong glycemic management while driving innovation in clinical research and practice.This fund will drive AGP and DTx-related research, with a focus on wearable monitoring tools, while promoting the generation of clinical evidence. It will facilitate the integration of industry, academia, and clinical practices, fostering a collaborative academic ecosystem. By enhancing scientific influence and generating real-world value, the fund aims to improve the lives of patients with diabetes and metabolic diseases worldwide.
If you are interested in learning more about the fund, please contact us via email for further information, including detailed funding guidelines, required materials for researchers, and to inquire whether your region is eligible for this funding.
Contact to: medicalaffairs.agpndtx@gmail.com
General Principles
(1) Applicants
Clinical researchers, bioengineers, and AI researchers.
(2) Aim
To support innovative scientific research based on CGM/CKM technologies.
(3) Funding Support
The Fund provides non-financial, in-kind support in the form of sensors. The quantity supplied is determined by the study design and approved by the review committee.For specific inquiries about the availability of Sibionics sensors in your region, please contact us via email.
Application: Project Types and Research Priorities
There are three types of projects that can apply for this fund.
(1) Clinical Research
This category focuses on generating clinical evidence for CGM and CKM in diabetes management, including their effectiveness in diverse populations and the combined use of CGM and CKM for early intervention in high-risk conditions.
(2) Interdisciplinary Research
This category focuses on integrating CGM and CKM with digital health solutions, including clinical decision support, automated insulin delivery, and AI-driven improvements.
(3) Exploratory Research
This category focuses on exploring innovative uses of CGM and CKM beyond traditional indications, including in specific high-risk populations and non-traditional areas like ketogenic diets.
Basic Requirements
(1) Basic Requirements
Eligible applicants are expected to have at least one peer-reviewed publication in diabetes technology or a related field within the past five years, and demonstrated capacity to independently design and conduct research.
(2) Preferred Qualifications
Affiliation with a top-250 QS World University or a recognized diabetes center, along with experience in clinical guideline or international multicenter research and a background in digital therapeutics, medical devices, or product design, is preferred.
Application Process and Timeline
Each project will be reviewed by a panel of at least three committee members, with the entire evaluation process conducted in a double-blind manner.
The entire process typically takes up to 6 months.
Authority & Interpretation
This fund is established and administered by the International Consortium for AGP & DTx R&D.The Consortium reserves the right to interpret these guidelines
Since funding support is limited, proposals not selected for funding may still be eligible to purchase sensors at a discounted rate.